The pediatric quality appraisal questionnaire: An instrument for evaluation of the pediatric health economics literature

Value in Health

Volumn 6, Issue 5, 2003, Pages 584-594

  Ungar, Wendy J ^a,b,c   Santos, Maria T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Economic evaluation; Pediatrics; Publication; Quality appraisal

Indexed keywords

ARTICLE; CHILD HEALTH CARE; ECONOMIC ASPECT; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; PEDIATRIC QUALITY APPRAISAL QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SCORING SYSTEM; VALIDATION PROCESS;

EID: 0141841676     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2003.65253.x     Document Type: Article

References (29)

1. Torrance G, Blaker D, Detsky A, et al. Canadian guidelines for economic evaluation of pharmaceuticals. Pharmacoeconomics 1996;9:535-59.
2. Jacobs J, Bachynsky J, Baladi J. A comparative review of pharmacoecomomic guidelines. Pharmacoeconomics 1995;8:182-9.
3. Jameson EJ, Wehr E. Drafting national health reform legislation to protect the health interests of children. Stanford Law Policy Rev 1993;Fall:152-76.
4. Starfield B, Newacheck P. Children's health status, health risks and use of health services. In: Schlesinger MJ, Eisenberg L, eds., Children in a Changing Health System: Assessments and Proposals for Reform. Baltimore: Johns Hopkins University Press, 1990.
5. Perrin JM. Introduction. In: Hobbs N, Perrin MJ, eds., Issues in the Care of Children with Chronic Illness. San Francisco: Jossey-Bass, 1985.
6. Bronfenbrenner U, Moen P, Garbarino J. Families and communities. In: Parke HR, ed., Review of Child Development Research. Chicago: University of Chicago Press, 1984.
7. Halfon N, Newacheck PW. Characterizing the social impact of asthma in children. In: Weiss KB, Buist AS, Sullivan SD, eds., Asthma's Impact on Society, the Social and Economic Burden. New York: Dekker, 2000.
8. Ungar W, Santos M. The Pediatric Economic Database Evaluation (PEDE) Project [Internet]. Technology Report No. 26. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002 Available from: http://www.ccohta.ca/entry_e.html.
9. Ganiats TG, Wong AF. Evaluation of cost-effectiveness research: a survey of recent publications. Fam Med 1991;23:457-62.
10. Adams ME, McCall NT, Gray DT, et al. Economic analysis in randomized control trials. Med Care 1992;30:231-43.
11. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med 1992;116:238-44.
12. Lee JT, Sanchez LA. Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature. Am J Hosp Pharm 1991;48:2622-7.
13. Gerard K. Cost-utility in practice: a policy maker's guide to the state of the art. Health Policy 1992;21:249-79.
14. Sacristan JA, Soto J, Galende I. Evaluation of pharmacoeconomic studies: utilization of a checklist. Ann Pharmacother 1993;27:1126-33.
15. Bradley CA, Iskedjian M, Lanctot KL, et al. Quality assessment of economic evaluations in selected pharmacy, medical, and health economics journals. Ann Pharmacother 1995;29:681-9.
16. Blackmore CC, Magid DJ. Methodologic evaluation of the radiology cost-effectiveness literature. Radiology 1997;203:87-91.
17. Iskedjian M, Trakas K, Bradley CA, et al. Quality assessment of economic evaluations published in PharmacoEconomics: the first four years (1992 to 1995). Pharmacoeconomics 1997;12:685-94.
18. Trakas K, Addis A, Kruk D, et al. Quality assessment of pharmacoeconomic abstracts of original research articles in selected journals. Ann Pharmacother 1997;31:423-8.
19. Canadian Coordinating Office for Health Technology Assessment. Guidelines for the Economic Evaluation of Pharmaceuticals: Canada [Internet] (2nd ed.). Ottawa: The Office, 1997. Available from: http://www.ccohta.ca/entry_e.html.
20. Drummond MF, O'Brien B, Stoddart GL, Torrance GW, eds. Methods for the Economic Evaluation of Health Care Programs (2nd ed.). Toronto: Oxford University Press, 1997.
21. Evidence-Based Medicine Working Group. Finding and Using an Article about an Economic Analysis [Internet]. Edmonton: Evidence-Based Medicine Working Group, University of Alberta, 2000. Available from: http://www.med.ualberta.ca/ebm/ econ.htm.
22. Gerard K, Seymour J, Smoker I. A tool to improve quality of reporting published economic analyses. Int J Technol Assess Health Care 2000;16:100-10.
23. Ontario Guidelines for Economic Analysis of Pharmaceutical Products [Internet]. Cat. No. 2227446. Toronto: Ontario Ministry of Health and Long-Term Care, 1994. Available from: http:// www.gov.on.ca/health/english/pub/drugs/drugpro/ economic.pdf.
24. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1339-41.
25. Elixhauser A, Halpern M, Schmier J, Luce BL. Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med Care 1998;36(5 Suppl):MS1-MS147.
26. Pritchard C. Trends in Economic Evaluation. OHE Briefing Number 36. London: Office of Health Economics, Health Economic Evaluations Database, 1998 Apr.
27. Drummond M, Brandt A, Luce B, Rovira J. Standardizing methodologies for economic evaluation in health care. Int J Technol Assess Health Care 1993;9:26-36.
28. Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1253-8.
29. Australia Commonwealth Department of Health Housing and Community Services. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee. Canberra: Commonwealth Department, 1992.